Stock Research: Innoviva

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Innoviva

NasdaqGS:INVA US45781M1018
69
  • Value
    89
  • Growth
    62
  • Safety
    Safety
    52
  • Combined
    84
  • Sentiment
    36
  • 360° View
    360° View
    69
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Innoviva, Inc. is a diversified holding company focused on healthcare assets. It operates in the healthcare industry, with a portfolio of respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA and ANORO ELLIPTA. It also has products like GIAPREZA and XERAVA. The company is based in the United States. In the last fiscal year, the company had a market cap of $1,257 million, profits of $322 million, revenue of $359 million, and 127 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 69 (better than 69% compared with alternatives), overall professional sentiment and financial characteristics for the stock Innoviva are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators above average for Innoviva. The consolidated Value Rank has an attractive rank of 52, which means that the share price of Innoviva is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 52% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 62, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. The company is also safely financed with a Safety Rank of 89. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of only 36. Professional investors are more confident in 64% other stocks. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 16-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 43 14 53
Growth
62 31 57 21
Safety
Safety
89 57 60 87
Sentiment
36 36 29 61
360° View
360° View
69 23 21 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
23 15 1 2
Opinions Change
50 50 50 50
Pro Holdings
n/a 86 98 98
Market Pulse
31 31 20 60
Sentiment
36 36 29 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
52 43 14 53
Growth
62 31 57 21
Safety Safety
89 57 60 87
Combined
84 25 31 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
77 70 50 89
Price vs. Earnings (P/E)
41 34 24 20
Price vs. Book (P/B)
51 45 41 64
Dividend Yield
1 1 1 1
Value
52 43 14 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
64 17 49 9
Profit Growth
98 8 15 30
Capital Growth
19 72 71 23
Stock Returns
37 67 77 87
Growth
62 31 57 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
48 41 30 50
Refinancing
79 42 55 41
Liquidity
77 78 85 94
Safety Safety
89 57 60 87

Similar Stocks

Discover high‑ranked alternatives to Innoviva and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.